APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,567,700 | +28.3% | 67,500 | +207.2% | 0.09% | +23.3% |
| Q2 2023 | $2,002,014 | -66.7% | 21,976 | -75.9% | 0.07% | -70.0% |
| Q1 2023 | $6,004,009 | +62.8% | 91,025 | +68.6% | 0.24% | +38.1% |
| Q3 2022 | $3,688,000 | +79.7% | 54,000 | +33.7% | 0.18% | +87.2% |
| Q1 2022 | $2,052,000 | -9.6% | 40,377 | -15.9% | 0.09% | -24.8% |
| Q4 2021 | $2,270,000 | +292.1% | 48,013 | +255.7% | 0.12% | +557.9% |
| Q1 2021 | $579,000 | – | 13,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |